HISORAD

Serial Number 79236377
Registration 5663786
700

Registration Progress

Application Filed
Feb 9, 2018
Under Examination
Approved for Publication
Nov 13, 2018
Published for Opposition
Nov 13, 2018
Registered
Jan 29, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-01-29) (Grace Period Filing)
Due: Jul 29, 2025 Grace Period - 16 days
Original deadline was Jan 29, 2025 (overdue)

Trademark Image

HISORAD

Basic Information

Serial Number
79236377
Registration Number
5663786
Filing Date
February 9, 2018
Registration Date
January 29, 2019
Published for Opposition
November 13, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 29, 2019
Registration
Registered
Classes
001

Rights Holder

Daicel Corporation

03
Address
3-1, Ofuka-cho, Kita-ku
Osaka-shi
Osaka 5300011
JP

Ownership History

Daicel Corporation

Original Applicant
03
Osaka JP

Daicel Corporation

Owner at Publication
03
Osaka JP

Daicel Corporation

Original Registrant
03
Osaka JP

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-01-29)
Due Date
January 29, 2025
Grace Period Ends
July 29, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description
Jan 29, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 28, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Dec 14, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 14, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 7, 2019 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2019 FIMP P FINAL DISPOSITION PROCESSED
May 23, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Apr 29, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 29, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 PUBO A PUBLISHED FOR OPPOSITION
Nov 13, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2018 GPNX P NOTIFICATION PROCESSED BY IB
Oct 24, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 24, 2018 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 24, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 1, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2018 ALIE A ASSIGNED TO LIE
Aug 25, 2018 RFNT P REFUSAL PROCESSED BY IB
Aug 17, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 17, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2018 RFRR P REFUSAL PROCESSED BY MPU
Aug 5, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 24, 2018 MAFR O APPLICATION FILING RECEIPT MAILED
Jul 19, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2018 DOCK D ASSIGNED TO EXAMINER
Jul 18, 2018 CNRT R NON-FINAL ACTION WRITTEN
Jul 16, 2018 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 12, 2018 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 001
Specialized excipient mixture without the pharmaceutical ingredient, used in the manufacture of rapidly disintegrating pharmaceutical tablets; chemical additives for use in the manufacture of food; chemical food additives for use in the manufacture of supplements; chemical food additives for use in the manufacture of nutritional supplements; chemicals, namely, disintegrating modifiers for use in the field of coating materials; excipients for use in the manufacture of pharmaceutical preparations and supplements; chemical agents for manufacturing supplements; chemicals used in industry; chemicals used in science, other than for medical or veterinary use; chemical preparations for use in the manufacture of pharmaceuticals, namely, raw materials and auxiliaries for the direct compression manufacturing of rapidly disintegrating tablets
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO